US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 2.070
  • +0.050+2.48%
Close Apr 26 16:00 ET
  • 2.060
  • -0.010-0.48%
Post 16:00 ET
32.62MMarket Cap-1800P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
-Cash and cash equivalents
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
-26.64%10.61M
-46.82%9.09M
321.68%11.08M
Receivables
--129.16K
--129.16K
----
----
----
--0
--0
----
----
----
-Other receivables
--129.16K
--129.16K
----
----
----
----
----
----
----
----
Prepaid assets
-60.08%105.78K
-60.08%105.78K
-68.70%105.72K
-23.03%89.94K
-13.72%206.6K
-10.28%264.96K
-10.28%264.96K
-36.33%337.81K
-66.08%116.86K
1,599.58%239.45K
Total current assets
-17.78%7.71M
-17.78%7.71M
-34.60%7.16M
0.29%9.24M
-34.77%7.39M
-29.25%9.38M
-29.25%9.38M
-26.98%10.95M
-47.20%9.21M
328.49%11.32M
Non current assets
Non current deferred assets
----
----
----
----
----
----
----
----
--50.25K
----
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--50.25K
--0
Total assets
-17.78%7.71M
-17.78%7.71M
-34.60%7.16M
-0.25%9.24M
-34.77%7.39M
-29.25%9.38M
-29.25%9.38M
-26.98%10.95M
-46.91%9.26M
279.71%11.32M
Liabilities
Current liabilities
Payables
-87.11%3.81K
-87.11%3.81K
97.34%11.72K
123.44%12.88K
189.69%18.41K
-53.39%29.54K
-53.39%29.54K
-51.08%5.94K
-94.06%5.76K
1,505.05%6.36K
-Other payable
-87.11%3.81K
-87.11%3.81K
97.34%11.72K
123.44%12.88K
189.69%18.41K
-53.39%29.54K
-53.39%29.54K
-51.08%5.94K
-94.06%5.76K
1,505.05%6.36K
Current accrued expenses
55.94%2.32M
55.94%2.32M
241.66%3M
572.05%2.97M
233.06%2.04M
447.13%1.49M
447.13%1.49M
96.24%879.49K
-75.46%442.03K
47.74%611.05K
Current liabilities
47.57%3.04M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
144.30%2.06M
65.92%1.18M
-75.30%473.88K
37.38%633.03K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
47.57%3.04M
47.57%3.04M
172.69%3.22M
537.17%3.02M
227.63%2.07M
144.30%2.06M
144.30%2.06M
65.92%1.18M
-75.30%473.88K
23.96%633.03K
Shareholders'equity
Share capital
24.42%14.47K
24.42%14.47K
12.18%13.01K
26.72%13.01K
13.73%11.67K
13.82%11.63K
13.82%11.63K
14.48%11.59K
3.50%10.26K
-99.94%10.26K
-common stock
24.42%14.47K
24.42%14.47K
12.18%13.01K
26.72%13.01K
13.73%11.67K
13.82%11.63K
13.82%11.63K
14.48%11.59K
3.50%10.26K
-99.94%10.26K
Retained earnings
-37.73%-53.22M
-37.73%-53.22M
---48.1M
---44.99M
---41.54M
---38.64M
---38.64M
----
----
----
Paid-in capital
25.96%57.87M
25.96%57.87M
15.27%52.03M
26.05%51.19M
17.41%46.84M
17.96%45.94M
17.96%45.94M
18.18%45.13M
16.74%40.61M
--39.9M
Gains losses not affecting retained earnings
----
----
----
----
----
----
----
-47.90%-35.38M
-65.15%-31.84M
-91.28%-29.22M
Total stockholders'equity
25.96%57.89M
25.96%57.89M
-59.70%3.93M
-29.24%6.22M
-50.31%5.31M
270.31%45.96M
270.31%45.96M
-31.62%9.76M
-43.40%8.79M
332.56%10.69M
Total equity
-36.20%4.67M
-36.20%4.67M
-59.70%3.93M
-29.24%6.22M
-50.31%5.31M
-41.06%7.32M
-41.06%7.32M
-31.62%9.76M
-43.40%8.79M
332.56%10.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M-46.82%9.09M321.68%11.08M
-Cash and cash equivalents -17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M-26.64%10.61M-46.82%9.09M321.68%11.08M
Receivables --129.16K--129.16K--------------0--0------------
-Other receivables --129.16K--129.16K--------------------------------
Prepaid assets -60.08%105.78K-60.08%105.78K-68.70%105.72K-23.03%89.94K-13.72%206.6K-10.28%264.96K-10.28%264.96K-36.33%337.81K-66.08%116.86K1,599.58%239.45K
Total current assets -17.78%7.71M-17.78%7.71M-34.60%7.16M0.29%9.24M-34.77%7.39M-29.25%9.38M-29.25%9.38M-26.98%10.95M-47.20%9.21M328.49%11.32M
Non current assets
Non current deferred assets ----------------------------------50.25K----
Total non current assets --0--0--0--0--0--0--0--0--50.25K--0
Total assets -17.78%7.71M-17.78%7.71M-34.60%7.16M-0.25%9.24M-34.77%7.39M-29.25%9.38M-29.25%9.38M-26.98%10.95M-46.91%9.26M279.71%11.32M
Liabilities
Current liabilities
Payables -87.11%3.81K-87.11%3.81K97.34%11.72K123.44%12.88K189.69%18.41K-53.39%29.54K-53.39%29.54K-51.08%5.94K-94.06%5.76K1,505.05%6.36K
-Other payable -87.11%3.81K-87.11%3.81K97.34%11.72K123.44%12.88K189.69%18.41K-53.39%29.54K-53.39%29.54K-51.08%5.94K-94.06%5.76K1,505.05%6.36K
Current accrued expenses 55.94%2.32M55.94%2.32M241.66%3M572.05%2.97M233.06%2.04M447.13%1.49M447.13%1.49M96.24%879.49K-75.46%442.03K47.74%611.05K
Current liabilities 47.57%3.04M47.57%3.04M172.69%3.22M537.17%3.02M227.63%2.07M144.30%2.06M144.30%2.06M65.92%1.18M-75.30%473.88K37.38%633.03K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 47.57%3.04M47.57%3.04M172.69%3.22M537.17%3.02M227.63%2.07M144.30%2.06M144.30%2.06M65.92%1.18M-75.30%473.88K23.96%633.03K
Shareholders'equity
Share capital 24.42%14.47K24.42%14.47K12.18%13.01K26.72%13.01K13.73%11.67K13.82%11.63K13.82%11.63K14.48%11.59K3.50%10.26K-99.94%10.26K
-common stock 24.42%14.47K24.42%14.47K12.18%13.01K26.72%13.01K13.73%11.67K13.82%11.63K13.82%11.63K14.48%11.59K3.50%10.26K-99.94%10.26K
Retained earnings -37.73%-53.22M-37.73%-53.22M---48.1M---44.99M---41.54M---38.64M---38.64M------------
Paid-in capital 25.96%57.87M25.96%57.87M15.27%52.03M26.05%51.19M17.41%46.84M17.96%45.94M17.96%45.94M18.18%45.13M16.74%40.61M--39.9M
Gains losses not affecting retained earnings -----------------------------47.90%-35.38M-65.15%-31.84M-91.28%-29.22M
Total stockholders'equity 25.96%57.89M25.96%57.89M-59.70%3.93M-29.24%6.22M-50.31%5.31M270.31%45.96M270.31%45.96M-31.62%9.76M-43.40%8.79M332.56%10.69M
Total equity -36.20%4.67M-36.20%4.67M-59.70%3.93M-29.24%6.22M-50.31%5.31M-41.06%7.32M-41.06%7.32M-31.62%9.76M-43.40%8.79M332.56%10.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg